105 related articles for article (PubMed ID: 18379432)
1. A comparison of huntington disease and huntington disease-like 2 neuropathology.
Rudnicki DD; Pletnikova O; Vonsattel JP; Ross CA; Margolis RL
J Neuropathol Exp Neurol; 2008 Apr; 67(4):366-74. PubMed ID: 18379432
[TBL] [Abstract][Full Text] [Related]
2. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
3. Huntington's Disease-like 2 (HDL2) in North America and Japan.
Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P
Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075
[TBL] [Abstract][Full Text] [Related]
4. Huntington's disease like-2: review and update.
Margolis RL; Rudnicki DD; Holmes SE
Acta Neurol Taiwan; 2005 Mar; 14(1):1-8. PubMed ID: 15835282
[TBL] [Abstract][Full Text] [Related]
5. A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features.
Bardien S; Abrahams F; Soodyall H; van der Merwe L; Greenberg J; Brink T; Carr J
Mov Disord; 2007 Oct; 22(14):2083-9. PubMed ID: 17708569
[TBL] [Abstract][Full Text] [Related]
6. TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease.
Reid SJ; van Roon-Mom WM; Wood PC; Rees MI; Owen MJ; Faull RL; Dragunow M; Snell RG
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):120-8. PubMed ID: 15193429
[TBL] [Abstract][Full Text] [Related]
7. Huntington's disease-like 2 in Brazil--report of 4 patients.
Rodrigues GG; Walker RH; Brice A; Cazeneuve C; Russaouen O; Teive HA; Munhoz RP; Becker N; Raskin S; Werneck LC; Junior WM; Tumas V
Mov Disord; 2008 Nov; 23(15):2244-7. PubMed ID: 18816802
[TBL] [Abstract][Full Text] [Related]
8. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
Ribchester RR; Thomson D; Wood NI; Hinks T; Gillingwater TH; Wishart TM; Court FA; Morton AJ
Eur J Neurosci; 2004 Dec; 20(11):3092-114. PubMed ID: 15579164
[TBL] [Abstract][Full Text] [Related]
9. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.
Krause A; Mitchell C; Essop F; Tager S; Temlett J; Stevanin G; Ross C; Rudnicki D; Margolis R
Am J Med Genet B Neuropsychiatr Genet; 2015 Oct; 168(7):573-85. PubMed ID: 26079385
[TBL] [Abstract][Full Text] [Related]
10. A Drosophila model of Huntington disease-like 2 exhibits nuclear toxicity and distinct pathogenic mechanisms from Huntington disease.
Krench M; Cho RW; Littleton JT
Hum Mol Genet; 2016 Aug; 25(15):3164-3177. PubMed ID: 27288455
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family.
Schneider SA; van de Warrenburg BP; Hughes TD; Davis M; Sweeney M; Wood N; Quinn NP; Bhatia KP
Neurology; 2006 Nov; 67(9):1701-3. PubMed ID: 17101913
[TBL] [Abstract][Full Text] [Related]
13. Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell death.
Gong B; Lim MC; Wanderer J; Wyttenbach A; Morton AJ
Brain Res Bull; 2008 Jan; 75(1):146-57. PubMed ID: 18158109
[TBL] [Abstract][Full Text] [Related]
14. Emerging differences between Huntington's disease-like 2 and Huntington's disease: A comparison using MRI brain volumetry.
Anderson DG; Haagensen M; Ferreira-Correia A; Pierson R; Carr J; Krause A; Margolis RL
Neuroimage Clin; 2019; 21():101666. PubMed ID: 30682531
[TBL] [Abstract][Full Text] [Related]
15. Huntington disease-like 2: insight into neurodegeneration from an African disease.
Krause A; Anderson DG; Ferreira-Correia A; Dawson J; Baine-Savanhu F; Li PP; Margolis RL
Nat Rev Neurol; 2024 Jan; 20(1):36-49. PubMed ID: 38114648
[TBL] [Abstract][Full Text] [Related]
16. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis.
Seixas AI; Holmes SE; Takeshima H; Pavlovich A; Sachs N; Pruitt JL; Silveira I; Ross CA; Margolis RL; Rudnicki DD
Ann Neurol; 2012 Feb; 71(2):245-57. PubMed ID: 22367996
[TBL] [Abstract][Full Text] [Related]
17. The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease.
Ferreira-Correia A; Krause A; Anderson DG
J Huntingtons Dis; 2020; 9(4):325-334. PubMed ID: 33044188
[TBL] [Abstract][Full Text] [Related]
18. Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains.
Hickman RA; Faust PL; Rosenblum MK; Marder K; Mehler MF; Vonsattel JP
Acta Neuropathol; 2021 Mar; 141(3):399-413. PubMed ID: 33517535
[TBL] [Abstract][Full Text] [Related]
19. Huntington disease-like 2: the first patient with apparent European ancestry.
Santos C; Wanderley H; Vedolin L; Pena SD; Jardim L; Sequeiros J
Clin Genet; 2008 May; 73(5):480-5. PubMed ID: 18341606
[TBL] [Abstract][Full Text] [Related]
20. Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype.
Costa MDC; Teixeira-Castro A; Constante M; Magalhães M; Magalhães P; Cerqueira J; Vale J; Passão V; Barbosa C; Robalo C; Coutinho P; Barros J; Santos MM; Sequeiros J; Maciel P
J Hum Genet; 2006; 51(8):645-651. PubMed ID: 16858508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
